Autres langues SK bioscience Co.,Ltd.

Actions

A302440

KR7302440003

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
58 300 ^KRW	-0,34 %		+2,28 %	-19,03 %

07/03	SK Bioscience inaugure l'agrandissement de son usine de fabrication en vue de l'extension de sa gamme de produits	CI
23/02	SK Bioscience obtient la certification de préqualification de l'Organisation mondiale de la santé	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SK Bioscience Signs Deal with Sanofi for Five Vaccine Types	28/03
SK Bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline	07/03
SK Bioscience Obtains Prequalification Certification from the World Health Organization	23/02
SK Bioscience's Net Income Plunges in Q4	02/02
SK Bioscience to Expand Facilities to Develop New Pneumococcal Vaccine	30/11
SK Group Advances Net Zero Transition via Key Renewable Energy Deal	27/11
SK Bioscience, Hilleman Laboratories Partner on Second-Gen Ebola Virus Vaccine	23/11
SK Bioscience Partners with Australian Company to Collaborate on Patch-Type Typhoid Vaccine Development	25/08/23
SK Bioscience Set to Deliver 5 Million Doses of Innovative Cell-Based Flu Vaccine SKYCellflu	24/08/23
SK Bioscience Boosts Partnership with Novavax via Acquisition of 6.5 Million Shares	10/08/23
MÄRKTE ASIEN/Uneinheitlich - Preisdaten dämpfen Stimmung in China	09/08/23
Novavax, Inc. announced that it expects to receive $84.5 million in funding from SK bioscience Co.,Ltd.	08/08/23
S.Korean shares hit 14-month high on platform, biopharma boost	01/08/23
SK Bioscience Swings to Loss in Q2	31/07/23
S.Korean shares end flat in wait-and-see mood; earnings, Fed in focus	19/07/23
SK Bioscience and Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate	30/06/23
South Korean Stocks Close Flat After Fed Rate Hike; SK Bioscience Rises 16%	04/05/23
MÄRKTE ASIEN/Börsen uneinheitlich mit leicht positivem Trend	04/05/23
SK Bioscience Swings to Loss in Q1; Shares Jump 15%	04/05/23
SK Bioscience Allots 2.4 Trillion Won for Contract Manufacturing Business	01/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SK bioscience Co.,Ltd.

Actions

A302440

KR7302440003

Autres langues

Filtres